The Inflation Reduction Act (IRA), signed by President Biden on August 16th, includes provisions to address prescription drug prices. While the measure is billed as a step toward stemming the drug pricing crisis, it is a baby step at best. A better approach would be to incentivize innovations that deliver better medicines more cheaply.
